Dr. Reddy’s

Dr. Reddy’s Laboratories on Friday (September 6, 2024) said it has received the establishment inspection report (EIR) from the U.S. health regulator for its active pharmaceutical ingredient manufacturing facility (CTO-6) …

Dr. Reddy’s had previously received EU (Good manufacturing practice) GMP certificate for its Rituximab drug substance and drug product manufacturing facility located in Hyderabad.  The Committee for Medicinal Products for …